Finance

Lists
003090:KRX
Daewoong Co Ltd
â‚©17,790.00
-1.39%
(-250.00) 1D
Sep 1, 3:30:25 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 003090...
Open
â‚©17,680
High
â‚©17,950
Low
â‚©17,560
Mkt. cap
1.03T
Avg. vol.
55.12K
Volume
52.44K
Dividend
1.12%
Quarterly dividend
â‚©50
Ex-dividend date
Dec 27, 2024
P/E ratio
4.10
52-wk high
â‚©30,600
52-wk low
â‚©15,410
EPS
â‚©4,341
Shares outstanding
58.14M
No. of employees
404
Open
â‚©17,680
High
â‚©17,950
Low
â‚©17,560
Mkt. cap
1.03T
Avg. vol.
55.12K
Volume
52.44K
Dividend
1.12%
Quarterly dividend
â‚©50
Ex-dividend date
Dec 27, 2024
P/E ratio
4.10
52-wk high
â‚©30,600
52-wk low
â‚©15,410
EPS
â‚©4,341
Shares outstanding
58.14M
No. of employees
404
About Daewoong Co Ltd
CEO-
Employees404
FoundedAug 15, 1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
542.18B
516.33B
492.71B
570.82B
Cost of goods sold
253.36B
253.72B
233.39B
256.79B
Cost of revenue
253.36B
253.72B
233.39B
256.79B
Research and development expenses
45.27B
50.47B
21.19B
20.88B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
156.79B
171.85B
182.87B
204.14B
Operating expense
208.27B
229.10B
211.53B
237.39B
Total operating expenses
461.63B
482.83B
444.93B
494.18B
Operating income
80.54B
33.51B
47.78B
76.64B
Other non operating income
-488.77M
4.85B
1.78B
-36.08B
EBT including unusual items
80.05B
49.71B
67.90B
40.56B
EBT excluding unusual items
80.05B
68.33B
45.89B
40.56B
Income tax expense
17.40B
-19.69B
14.64B
4.23B
Effective tax rate
21.73%
-39.60%
21.56%
10.42%
Other operating expenses
2.22B
1.60B
2.62B
2.00B
Net income
40.13B
69.88B
35.26B
34.13B
Net profit margin
7.40%
13.53%
7.16%
5.98%
Earnings per share
-
-
-
-
Interest and investment income
-
1.86B
3.71B
-
Interest expense
-
-3.98B
-8.80B
-
Net interest expenses
-
-2.13B
-5.09B
-
Depreciation and amortization charges
2.41B
1.38B
1.12B
8.25B
EBITDA
95.81B
51.09B
68.08B
105.96B
Gain or loss from assets sale
-14.78M
-39.74B
56.20M
28.02M
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps